Masimo (MASI) Cut to Sell at BidaskClub

BidaskClub downgraded shares of Masimo (NASDAQ:MASI) from a hold rating to a sell rating in a report published on Thursday morning.

MASI has been the subject of several other reports. BTIG Research raised shares of Masimo from a neutral rating to a buy rating and set a $100.00 target price for the company in a research report on Monday, August 14th. Zacks Investment Research downgraded shares of Masimo from a buy rating to a hold rating in a research report on Tuesday, October 3rd. Finally, Stifel Nicolaus reissued a buy rating and set a $108.00 target price on shares of Masimo in a research report on Friday, November 3rd. One research analyst has rated the stock with a sell rating, three have given a hold rating and five have issued a buy rating to the stock. The company currently has a consensus rating of Hold and an average target price of $97.17.

Masimo (NASDAQ:MASI) traded up $0.48 on Thursday, reaching $86.00. 396,352 shares of the company’s stock traded hands, compared to its average volume of 340,552. Masimo has a 12-month low of $63.71 and a 12-month high of $104.71. The company has a market capitalization of $4,443.71, a P/E ratio of 32.95, a P/E/G ratio of 2.90 and a beta of 0.72.

Masimo (NASDAQ:MASI) last posted its quarterly earnings results on Tuesday, October 31st. The medical equipment provider reported $0.70 earnings per share for the quarter, beating the consensus estimate of $0.53 by $0.17. Masimo had a net margin of 45.83% and a return on equity of 22.17%. The firm had revenue of $193.69 million during the quarter, compared to the consensus estimate of $189.01 million. During the same period in the previous year, the firm posted $0.52 earnings per share. The business’s revenue was up 15.6% compared to the same quarter last year. equities research analysts expect that Masimo will post 2.95 earnings per share for the current year.

In related news, Director Steven Barker sold 10,000 shares of the business’s stock in a transaction dated Wednesday, November 1st. The shares were sold at an average price of $90.00, for a total transaction of $900,000.00. Following the transaction, the director now directly owns 73,249 shares in the company, valued at $6,592,410. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Yongsam Lee sold 5,900 shares of the business’s stock in a transaction dated Friday, December 1st. The stock was sold at an average price of $88.31, for a total transaction of $521,029.00. Following the transaction, the executive vice president now owns 70,800 shares in the company, valued at $6,252,348. The disclosure for this sale can be found here. Over the last three months, insiders have sold 53,074 shares of company stock valued at $4,737,245. 16.60% of the stock is currently owned by insiders.

Institutional investors have recently added to or reduced their stakes in the stock. Prudential Financial Inc. boosted its holdings in Masimo by 14.4% during the second quarter. Prudential Financial Inc. now owns 553,215 shares of the medical equipment provider’s stock worth $50,442,000 after purchasing an additional 69,810 shares during the last quarter. State Street Corp boosted its holdings in Masimo by 10.4% during the second quarter. State Street Corp now owns 1,547,728 shares of the medical equipment provider’s stock worth $141,121,000 after purchasing an additional 146,212 shares during the last quarter. American Century Companies Inc. boosted its holdings in Masimo by 98.0% during the second quarter. American Century Companies Inc. now owns 209,474 shares of the medical equipment provider’s stock worth $19,100,000 after purchasing an additional 103,656 shares during the last quarter. D L Carlson Investment Group Inc. boosted its holdings in Masimo by 32.4% during the second quarter. D L Carlson Investment Group Inc. now owns 46,240 shares of the medical equipment provider’s stock worth $4,216,000 after purchasing an additional 11,315 shares during the last quarter. Finally, Robeco Institutional Asset Management B.V. boosted its holdings in Masimo by 27.1% during the second quarter. Robeco Institutional Asset Management B.V. now owns 1,095,353 shares of the medical equipment provider’s stock worth $99,872,000 after purchasing an additional 233,412 shares during the last quarter. Institutional investors and hedge funds own 83.74% of the company’s stock.

WARNING: “Masimo (MASI) Cut to Sell at BidaskClub” was first posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this report on another domain, it was illegally copied and reposted in violation of U.S. & international copyright & trademark legislation. The correct version of this report can be read at https://ledgergazette.com/2017/12/10/masimo-masi-cut-to-sell-at-bidaskclub.html.

Masimo Company Profile

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Analyst Recommendations for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Co. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply